<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Adapting to insulin resistance in obesity: role of insulin secretion and clearance</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-12-01">1 December 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sang-Hee</forename><surname>Jung</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Obstetrics and Gynaecology</orgName>
								<orgName type="institution" key="instit1">CHA Bundang Medical Centre</orgName>
								<orgName type="institution" key="instit2">CHA University</orgName>
								<address>
									<settlement>Seongnam</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chan-Hee</forename><surname>Jung</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Endocrinology and Metabolism</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Soonchunhyang University School of Medicine</orgName>
								<orgName type="institution" key="instit2">Bucheon Hospital</orgName>
								<address>
									<settlement>Bucheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerald</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Division of Endocrinology, Gerontology and Metabolism</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Stanford University Medical Center</orgName>
								<address>
									<addrLine>300 Pasteur Drive, Room S025</addrLine>
									<postCode>94305-5103</postCode>
									<settlement>Stanford</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Sun</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
							<email>sunhkim@stanford.edu</email>
							<affiliation key="aff2">
								<orgName type="department">Division of Endocrinology, Gerontology and Metabolism</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Stanford University Medical Center</orgName>
								<address>
									<addrLine>300 Pasteur Drive, Room S025</addrLine>
									<postCode>94305-5103</postCode>
									<settlement>Stanford</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Adapting to insulin resistance in obesity: role of insulin secretion and clearance</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-12-01">1 December 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">0950EDF5D16FF2224A168D4EBA5DC201</idno>
					<idno type="DOI">10.1007/s00125-017-4511-0</idno>
					<note type="submission">Received: 14 June 2017 / Accepted: 1 November 2017 /</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:10+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Hyperinsulinaemia</term>
					<term>Insulin clearance rate</term>
					<term>Insulin resistance</term>
					<term>Insulin secretion rate</term>
					<term>Obesity</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Aims/hypothesis The aim of this study was to quantify the relative contributions of increased insulin secretion rate (ISR) and decreased insulin clearance rate (ICR) in the compensatory hyperinsulinaemia characteristic of insulin-resistant individuals without diabetes.</s><s>Methods Obese (BMI ≥30 kg/m 2 ) individuals without diabetes (n = 91) were identified from a registry of volunteers.</s><s>Volunteers underwent the following measurements: oral glucose tolerance; insulin resistance (steady-state plasma glucose [SSPG] concentration during the insulin suppression test [IST]); ISR (using the graded glucose infusion test [GGIT]); and ICR (using the IST and GGIT).</s><s>Participants were stratified into tertiles based on SSPG concentration: SSPG-1(insulin-sensitive); SSPG-2 (intermediate); and SSPG-3 (insulin-resistant). Results There were no differences in BMI and waist circumference among the SSPG tertiles.</s><s>Serum alanine aminotransferase concentrations were higher in the SSPG-2 and SSPG-3 groups compared with the SSPG-1 group (p = 0.02).</s><s>Following an oral glucose challenge, there was a progressive increase in the total integrated insulin response from the most insulin-sensitive to the most insulin-resistant tertiles (p &lt; 0.001).</s><s>Following intravenous glucose, the SSPG-3 group had significantly greater integrated glucose (median [interquartile range], 32.9 [30.8-36.3]</s><s>mmol/l × h) and insulin responses (1711 [1476-2223]  mmol/l × h) compared with the SSPG-1 group (30.3 [28.8-32.9]</s><s>mmol/l × h, p = 0.04, and 851 [600-1057] pmol/l × h, p &lt; 0.001, respectively).</s><s>Furthermore, only the SSPG-3 group had significant changes in both ISR and ICR (p &lt; 0.001).</s><s>In the SSPG-2 group, only the ICR was significantly decreased compared with the SSPG-1 group.</s><s>Therefore, ICR progressively declined during the IST with increasing insulin resistance (SSPG-1, 0.48 [0.41-0.59];</s><s>SSPG-2, 0.43 [0.39-0.50];</s><s>).</s><s>Conclusions/interpretation While both increases in ISR and decreases in ICR compensate for insulin resistance, decreases in ICR may provide the first adaptation to decreased insulin sensitivity.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Currently, the pathogenesis of type 2 diabetes is thought to involve the failure of pancreatic beta cells to secrete sufficient insulin to satisfy demand in the context of obesity and/or increased insulin resistance <ref type="bibr" target="#b0">[1]</ref>.While this hypothesis is widely accepted, an increase in the insulin secretion rate (ISR) is not the only adaptation to insulin resistance.</s><s>Decreases in the insulin clearance rate (ICR) also help to maintain hyperinsulinaemia in insulin-resistant states <ref type="bibr" target="#b1">[2]</ref>.</s><s>However, the relative roles of increases in ISR vs decreases in ICR in maintaining hyperinsulinaemia and glucose tolerance in insulin resistance are unclear.</s></p><p><s>The aim of this study was to better understand the physiological adaptations to insulin resistance prior to the development of type 2 diabetes in a sample of 91 obese individuals who have had direct measurements of insulin resistance using the insulin suppression test (IST).</s><s>We compared glucose tolerance, ISR and ICR in equally obese individuals with varying degrees of insulin sensitivity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The study population consisted of 91 individuals who had previously responded to an advertisement seeking volunteers for research studies on the role of insulin resistance in human disease.</s><s>All individuals were apparently healthy without coronary, kidney or liver disease.</s><s>The Stanford Institutional Review Board approved all studies and all participants provided informed consent.</s></p><p><s>We identified 152 individuals in our ongoing registry of participants who had undergone an OGTT, IST and graded glucose infusion test (GGIT).</s><s>For the current study, we included individuals with obesity (BMI ≥30 kg/m 2 , n = 96).</s><s>Five additional individuals were excluded for having 2 h glucose ≥11 mmol/l <ref type="bibr" target="#b2">[3]</ref>.</s><s>Therefore, 91 participants were included in the final sample.</s></p><p><s>The study population was stratified into tertiles based on their degree of insulin resistance as defined by their steadystate plasma glucose (SSPG) concentration during the IST as described below.</s></p><p><s>IST Peripheral insulin resistance was directly measured with the modified version of the IST <ref type="bibr" target="#b3">[4]</ref>.</s><s>Measures of insulin action with the IST are highly correlated (r ≥ 0.87) with those obtained with the hyperinsulinaemic-euglycaemic clamp <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>In brief, after an overnight fast, an intravenous catheter was placed in each of the participants' arms.</s><s>One arm was used for the administration of a 180 min infusion of octreotide (0.27 mg m −2 min −1 ), insulin (32 mU m −2 min −1 ) and glucose (267 mg m −2 min −1 ); the other arm was used for collecting blood samples.</s><s>Blood was drawn at 10 min intervals from 150 min to 180 min of the infusion to determine the SSPG and steady-state plasma insulin (SSPI) concentrations.</s><s>Under these conditions SSPI concentration was comparable for all participants and the SSPG concentration provides a direct measure of the ability of insulin to mediate disposal of an infused glucose load; the higher the SSPG concentration, the greater the degree of insulin resistance.</s><s>Based on the SSPG concentrations, the population was divided into tertiles:insulin-sensitive (SSPG-1); intermediate (SSPG-2); and insulin-resistant (SSPG-3).</s></p><p><s>OGTT All participants underwent a 75 g OGTT in which plasma glucose and insulin concentrations were measured before and 30, 60, 120 and 180 min after the glucose challenge.</s><s>The AUCs for glucose (G-AUC) and insulin (I-AUC) were calculated using the trapezoidal method.</s></p><p><s>GGIT All participants received graded intravenous infusions of glucose at progressively increasing rates (1, 2, 3, 4, 6 and 8 mg kg −1 min −1 ) as previously described <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>.</s><s>Each glucose infusion rate was administered for a total of 40 min.</s><s>Glucose, insulin and C-peptide concentrations were measured at 0, <ref type="bibr">30,</ref><ref type="bibr">40,</ref><ref type="bibr">70,</ref><ref type="bibr">80,</ref><ref type="bibr">110,</ref><ref type="bibr">120,</ref><ref type="bibr">150,</ref><ref type="bibr">160,</ref><ref type="bibr">190,</ref><ref type="bibr">200</ref>, 230 and 240 min.</s><s>The last two glucose and insulin values at the end of each 40 min infusion period (e.g. 30 and 40 min values) were averaged and used as the mean for that infusion.</s></p><p><s>Measurement of ISR ISRs were derived by deconvolution covering 240 min and 13 sampling time points for peripheral plasma C-peptide concentrations, using a two-compartment model of C-peptide kinetics and standard variables for Cpeptide clearance estimated for each participant based on body surface area and age <ref type="bibr" target="#b8">[9]</ref>.</s><s>Previously, we have also used 25 sampling time points <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>In a subset of 14 individuals, we found no significant differences in ISR using 13 vs 25 sampling time points (S.</s><s>H. Kim, unpublished data).</s><s>For each participant, the mean ISR before and during the six glucose infusion periods was plotted against the corresponding mean glucose to construct a dose-response relationship.</s><s>The beta cell sensitivity represented the slope of the line relating glucose and ISR.</s></p><p><s>Measurement of ICR ICR was calculated during the IST and GGIT.</s><s>During the IST, ICR was calculated by dividing the insulin infusion rate by the SSPI concentration <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s>As octreotide is infused to inhibit endogenous insulin secretion, ICR during the IST represents exogenous ICR (ICR ex ).</s><s>During the GGIT, ICR was calculated by using the following formula:</s></p><formula xml:id="formula_0">ISR−AUC I−AUC − VÂI t240 ð Þ−I t0 ð Þ I−AUC :</formula><p><s>The AUCs for ISR and insulin were calculated using the trapezoidal method.</s><s>V refers to volume of distribution of insulin, which was estimated as 0.14 l/kg <ref type="bibr" target="#b11">[12]</ref>.</s><s>I refers to insulin concentration at time (t) 0 min and 240 min.</s></p><p><s>Metabolic measurements Glucose was determined by the oxidase (Analyzer 2; Beckman, Brea, CA, USA).</s><s>Insulin and C-peptide concentrations were measured at Washington University (St Louis, MO, USA) using radioimmunoassay (Millipore, St Charles, MO, USA).</s><s>The inter-and intra-assay coefficient of variation ranged between 4.7% and 9.7% for insulin, and 5.2% and 10.9% for C-peptide.</s><s>Creatinine and alanine aminotransferase (ALT) were measured in the clinical laboratory at Stanford Health Care (Stanford, CA, USA).</s></p><p><s>Statistical analysis Statistical analysis was performed using SPSS (version 23 for Windows; SPSS, Armonk, NY, USA).</s><s>Data are reported as mean ± SD or median (interquartile range).</s><s>Non-parametric variables were log-transformed prior to analyses.</s><s>Comparisons among groups were made using one-way ANOVA.</s><s>A probability value of &lt;0.05 was considered to be statistically significant in all analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Table <ref type="table" target="#tab_0">1</ref> presents the demographic and clinical characteristics of the study population stratified into tertiles based on degree of insulin resistance (SSPG concentration).</s><s>By selection, magnitude of insulin resistance increased progressively from the least (SSPG-1) to the most insulin-resistant tertile (SSPG-3).</s><s>Despite the dramatic differences in SSPG concentration, the three groups were otherwise well matched and did not differ in age, sex distribution, race/ethnicity, BMI, waist circumference or fasting plasma glucose concentration.</s><s>However, ALT concentrations were significantly higher and creatinine concentration was lower in the two most insulin-resistant groups (SSPG-2 and SSPG-3).</s></p><p><s>Plasma glucose and insulin concentrations following the oral glucose challenge are shown in Fig. <ref type="figure">1</ref>.</s><s>The total area under the glucose response curves (G-AUC) of the three groups are illustrated in Fig. <ref type="figure">1a</ref>.</s><s>The three groups were significantly different (p = 0.001), with the G-AUC of the most insulin-resistant tertile (SSPG-3) being significantly higher than the other two groups (p &lt; 0.05).</s><s>The insulin responses (I-AUC) of the three SSPG groups to oral glucose (Fig. <ref type="figure">1b</ref>) separated more dramatically (p &lt; 0.001) and I-AUC increased progressively from the most insulin-sensitive to the most insulin-resistant tertile.</s></p><p><s>Figure <ref type="figure">2</ref> presents the changes in plasma glucose and insulin concentrations and ISR in response to the graded glucose infusion in the three SSPG groups.</s><s>The quantitative comparisons between the three groups are shown in Table <ref type="table" target="#tab_1">2</ref>. Plasma glucose concentrations increased modestly in all three groups (Fig. <ref type="figure">2a</ref>), with the G-AUC being significant higher in the most insulin-resistant group (SSPG-3) compared with the most insulin-sensitive group (SSPG-1).</s><s>The changes in insulin concentration and ISR (Fig. <ref type="figure">2b, c</ref>) in response to the intravenous glucose infusion were more pronounced in the most insulinresistant tertile (SSPG-3), and the AUCs were significantly greater in this group than in the other two groups.</s></p><p><s>The changes in ICR, as measured during the GGIT and IST, are illustrated in Fig. <ref type="figure" target="#fig_1">3</ref>.</s><s>During the GGIT, endogenous ICR (ICR en ) differed among the three groups (p &lt; 0.001).</s><s>In contrast to insulin concentration and ISR, ICR en progressively decreased from the most insulin-sensitive to the most insulin-resistant tertiles (Fig. <ref type="figure" target="#fig_1">3a</ref>).</s><s>That is, ICR en was significantly lower in SSPG-2 vs SSPG-1 (p = 0.03) and SSPG-3 vs SSPG-2 (p = 0.003).</s><s>The results were similar when ICR ex was calculated during the IST (Fig. <ref type="figure" target="#fig_1">3b</ref>).</s><s>Thus, ICR ex was highest in the SSPG-1 group, intermediate in the SSPG-2 group and lowest in the SSPG-3 group (all pairwise comparisons were p &lt; 0.05).</s><s>Finally, the relationship between the plasma glucose concentration and ISR were compared among the three SSPG groups.</s><s>As shown in Fig. <ref type="figure">4</ref>, the curve in the most insulinresistant group (SSPG-3) shifted upward and to the left.</s><s>Thus, the individuals in the SSPG-3 group had significantly higher beta cell sensitivity to glucose (Table <ref type="table" target="#tab_1">2</ref>) and secreted more insulin at any given plasma glucose concentration compared with the other more insulin-sensitive groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The aim of the current analysis was to understand how obese individuals adapt to the demands of insulin resistance prior to the development of type 2 diabetes.</s><s>By evaluating equally obese individuals with varying degrees of insulin sensitivity, we were able to define the relative contributions of ISR and ICR in maintaining hyperinsulinaemia as the magnitude of insulin resistance increased.</s><s>The most novel finding was seen in the group with intermediate insulin resistance (SSPG-2), who had a significant decrease in ICR but no change in ISR compared with the insulin-sensitive group (SSPG-1).</s><s>The most insulin-resistant group (SSPG-3) had a significant decrease in ICR and an increase in ISR compared with the insulin-sensitive group.</s><s>This suggests that the first compensation for insulin resistance is a decrease in ICR, which occurs prior to any significant increase in ISR.</s></p><p><s>Prior studies have shown significant differences in ISR and ICR in insulin-resistant vs insulin-sensitive groups <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>In the majority of these studies <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>, degree of obesity and not direct measurement of insulin resistance was used to identify individuals as insulin-resistant vs insulin-sensitive.</s><s>This is problematic as we have recently shown that obesity itself can increase ISR <ref type="bibr" target="#b15">[16]</ref>.</s><s>Furthermore, we have previously used the IST to identify non-obese insulin-sensitive and insulinresistant individuals <ref type="bibr" target="#b1">[2]</ref>.</s><s>Similar to the comparisons between the SSPG-3 and SSPG-1 groups in the present study, we found significant increases in ISR and decreases in ICR in insulin- Glucose infusion rate (mg kg -1 min -1 )</s></p><p><s>Fig. <ref type="figure">2</ref> (a) Glucose, (b) insulin and (c) ISR during the GGIT are shown for the SSPG-1 (white circles), SSPG-2 (black triangles) and SSPG-3 (black squares) groups.</s><s>The G-AUC (p = 0.04), I-AUC (p &lt; 0.001) and ISR-AUC (p &lt; 0.001) differed among the groups, using ANOVA.</s><s>The most insulin-resistant group (SSPG-3) had the highest G-AUC, I-AUC and ISR-AUC.</s><s>In post hoc analysis, there were no significant differences between the SSPG-1 and SSPG-2 groups.</s><s>Data are means ± SEM resistant individuals compared with insulin-sensitive individuals.</s><s>However, since these comparisons were performed in dichotomous groups, insulin-resistant vs insulin-sensitive, the results did not permit an evaluation of the potential importance of differences in magnitude of insulin resistance.</s></p><p><s>By comparing the three SSPG groups, our study demonstrates the importance of ICR in adapting to the demands of insulin resistance, as it appears to occur prior to a significant increase in ISR.</s><s>While we are unaware of other human studies demonstrating the early role of ICR in insulin resistance, a longitudinal study in dogs demonstrated the relevance of ICR in maintaining hyperinsulinaemia in insulin resistance <ref type="bibr" target="#b16">[17]</ref>.</s><s>The dogs were fat-fed for 12 weeks and had a significant increase in fasting hyperinsulinaemia and insulin resistance.</s><s>ISR transiently increased at 6 weeks but returned to baseline at 12 weeks.</s><s>At the end of the study, hyperinsulinaemia was maintained due to a significant decrease in ICR.</s><s>The authors speculated that a decrease in insulin catabolism may help 'rest' the beta cells in the face of chronic insulin resistance.</s><s>As our study was cross-sectional, we cannot comment on the dynamic changes in ISR and ICR as insulin resistance develops.</s><s>However, it is clear that ICR plays an important and early role in maintaining hyperinsulinaemia in insulin resistance.</s></p><p><s>The mechanism for the decrease in ICR in insulin resistance remains unclear but could relate to an increase in hepatic lipid associated with insulin resistance <ref type="bibr" target="#b17">[18]</ref>.</s><s>The liver is the major site for insulin degradation <ref type="bibr" target="#b18">[19]</ref> and hepatic steatosis has been shown to correlate negatively with ICR <ref type="bibr" target="#b19">[20]</ref>.</s><s>Consistent with this possibility are the findings of similarly elevated ALT concentrations in the SSPG-2 and SSPG-3 groups compared with the most insulin-sensitive group (SSPG-1).</s></p><p><s>Although ICR is important in maintaining hyperinsulinaemia in insulin resistance, the decrease in ICR is apparently not sufficient compensation in the most insulin-resistant tertile (SSPG-3), whose SSPG concentration was double that of the most insulinsensitive tertile (SSPG-1).</s><s>In these people, the hyperinsulinaemia is the result of both a decrease in ICR and an increase in ISR.</s><s>Interestingly, the glucose concentration was also significantly, albeit modestly, increased in the SSPG-3 group compared with the SSPG-1 group.</s><s>The modest increase in blood glucose is likely to have a direct effect on pancreatic beta cell insulin synthesis and secretion <ref type="bibr" target="#b20">[21]</ref>.</s><s>In support, beta cell sensitivity to glucose was significantly increased in the SSPG-3 group, as demonstrated by the upward shift in the ISR curve in Fig. <ref type="figure">4</ref>.</s></p><p><s>Based upon our findings, we propose the following overall hypothesis to describe the adaptation to insulin resistance in obesity prior to the development of type 2 diabetes.</s><s>A relative modest degree of insulin resistance is associated with an  increase in hepatic fat content, leading to a decrease in ICR and, based on the findings shown in Fig. <ref type="figure">1</ref>, an increase in plasma insulin concentrations sufficient to maintain euglycaemia.</s><s>However, the decrease in ICR is not sufficient compensation in the most insulin-resistant tertile (SSPG-3); in these people, hyperinsulinaemia is the result of both a decrease in ICR and an increase in ISR.</s></p><p><s>There are limitations to our study.</s><s>First, the data were crosssectional, derived from prior experimental studies, and selected to include only obese individuals.</s><s>Furthermore, despite the fact that overall (BMI) and abdominal (waist circumference) obesity of the three groups were essentially identical (Table <ref type="table" target="#tab_0">1</ref>), the analysis lacks direct measurements of regional fat distribution.</s><s>Thus, the conclusion that the relationships among insulin resistance, plasma insulin concentration, ISR and ICR discerned in the analysis are independent of differences in adiposity should be tempered.</s><s>Furthermore, we used a modified protocol for sampling blood (13 vs 25), which may have affected calculation of ISR and ICR.</s><s>Nevertheless, the qualitative results for ICR were similar to calculations based on the IST.</s><s>Finally, we did not measure hormones, in particular incretin hormones, which also play significant roles in postprandial glucose and insulin modulation <ref type="bibr" target="#b21">[22]</ref>.</s><s>Differences in incretin hormones may also explain the differences in plasma insulin concentration during the OGTT among the three groups compared with during the GGIT.</s><s>Despite these shortcomings, we are unaware of published specific quantitative measurements of insulin resistance, ISR and ICR in obese, apparently healthy individuals over a wide range of insulin resistance.</s><s>As such, our findings provide a coherent view demonstrating the relative changes in ICR and ISR with increases in insulin resistance.</s><s>While changes in both ISR and ICR occur, decreases in ICR may provide the first adaptation to decreased insulin sensitivity.</s><s>The relationship between glucose and ISR is shown for the SSPG-1 (white circles), SSPG-2 (black triangles) and SSPG-3 (black squares) groups.</s><s>The curve, representing beta cell sensitivity to glucose, was shifted up and to the left in the most insulin-resistant group (SSPG-3) compared with the other two groups (p = 0.01).</s><s>Data are means ± SEM</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Fig.1(a) Glucose and (b) insulin concentrations during the OGTT are shown for the SSPG-1 (white circles), SSPG-2 (black triangles) and SSPG-3 (black squares) groups.</s><s>G-AUC and I-AUC significantly differed among the three SSPG groups (p ≤ 0.001).</s><s>The most insulinresistant group (SSPG-3) had the highest G-AUC and I-AUC.</s><s>Data are means ± SEM</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>)Fig. 3</head><label>3</label><figDesc><div><p><s>Fig.3ICR en and ICR ex are shown for the SSPG-1, SSPG-2 and SSPG-3 groups during the (a) GGIT and (b) IST.</s><s>Both measures of ICR progressively declined from SSPG-1 to SSPG-3.</s><s>All pairwise comparisons were significantly different (p &lt; 0.05).</s><s>Data are means ± SEM</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Fig. 4The relationship between glucose and ISR is shown for the SSPG-1 (white circles), SSPG-2 (black triangles) and SSPG-3 (black squares) groups.</s><s>The curve, representing beta cell sensitivity to glucose, was shifted up and to the left in the most insulin-resistant group (SSPG-3) compared with the other two groups (p = 0.01).</s><s>Data are means ± SEM</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc></figDesc><table><row><cell>Characteristics of obese individuals (BMI ≥30 kg/</cell><cell>SSPG-1</cell><cell>SSPG-2</cell><cell>SSPG-3</cell><cell>p value</cell></row><row><cell>m 2 ) by SSPG tertile</cell><cell>(&lt;9.7 mmol/l)</cell><cell>(9.7-12.7 mmol/l)</cell><cell>(≥12.8 mmol/l)</cell><cell></cell></row><row><cell>n</cell><cell>30</cell><cell>31</cell><cell>30</cell><cell></cell></row><row><cell>SSPG, mmol/l</cell><cell>7.2 ± 2.0</cell><cell>11.3 ± 0.9 a,b</cell><cell>14.3 ± 1.2 b,c</cell><cell>&lt;0.001</cell></row><row><cell>Age, years</cell><cell>54.3 ± 9.2</cell><cell>54.1 ± 10.5</cell><cell>52.8 ± 9.7</cell><cell>0.82</cell></row><row><cell>Female sex, n (%)</cell><cell>21 (70)</cell><cell>20 (65)</cell><cell>18 (60)</cell><cell>0.71</cell></row><row><cell>Non-Hispanic white, n (%)</cell><cell>24 (80)</cell><cell>20 (65)</cell><cell>18 (60)</cell><cell>0.21</cell></row><row><cell>BMI, kg/m 2</cell><cell>33.7 ± 2.3</cell><cell>33.7 ± 2.4</cell><cell>33.8 ± 2.2</cell><cell>0.99</cell></row><row><cell>Waist circumference, cm</cell><cell>110.7 ± 7.5</cell><cell>110.3 ± 8.8</cell><cell>110.6 ± 9.0</cell><cell>0.98</cell></row><row><cell>Fasting glucose, mmol/l</cell><cell>5.8 ± 0.5</cell><cell>5.8 ± 0.5</cell><cell>6.0 ± 0.4</cell><cell>0.11</cell></row><row><cell>ALT, U/l</cell><cell>36 ± 14</cell><cell>45 ± 14 a</cell><cell>48 ± 26 c</cell><cell>0.02</cell></row><row><cell>Creatinine, μmol/l</cell><cell>88.4 ± 17.7</cell><cell>79.6 ± 17.7 a</cell><cell>79.6 ± 17.7</cell><cell>0.04</cell></row></table><note><p><s>Data are presented as mean ± SD or n (%) a Significant difference between tertile 1 and 2 b Significant difference between tertile 2 and 3 c Significant difference between tertile 1 and 3</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc></figDesc><table><row><cell>Quantitative results of the GGIT by SSPG tertile</cell><cell>SSPG-1</cell><cell>SSPG-2</cell><cell>SSPG-3</cell><cell>p value</cell></row><row><cell></cell><cell>(&lt;9.7 mmol/l)</cell><cell>(9.7-12.7 mmol/l)</cell><cell>(≥12.8 mmol/l)</cell><cell></cell></row><row><cell>n</cell><cell>30</cell><cell>31</cell><cell>30</cell><cell></cell></row><row><cell>G-AUC (0-4h) (mmol/l×h)</cell><cell>30.3 (28.8-32.9)</cell><cell>32.8 (29.0-33.8)</cell><cell>32.9 (30.8-36.3) c</cell><cell>0.04</cell></row><row><cell>I-AUC (0-4h) (pmol/l×h)</cell><cell>851 (600-1057)</cell><cell>945 (689-1277) b</cell><cell cols="2">1711 (1476-2223) b,c &lt;0.001</cell></row><row><cell cols="5">ISR-AUC (0-4h) (pmol/min×h) 1929 (1625-2365) 1912 (1471-2489) b 2744 (2426-3681) b,c &lt;0.001</cell></row><row><cell>Beta cell sensitivity</cell><cell>124 (87-187)</cell><cell>115 (59-173) b</cell><cell>171 (118-242) b</cell><cell>0.01</cell></row><row><cell>(pmol/min×mmol/l)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Data are presented as median (interquartile range)</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">a Significant difference between tertile 1 and 2</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">b Significant difference between tertile 2 and 3</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">c Significant difference between tertile 1 and 3</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Diabetologia (2018)  61:681-687</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acknowledgements The authors would like to thank the volunteers and the staff and nurses in the Stanford Clinical and Translational Research Unit for their invaluable assistance with our metabolic studies.</s><s>Some of the data in this manuscript were presented as an abstract at the ADA 77th Scientific Sessions in 2017.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p><s>The datasets analysed during the current study are not publicly available for reasons of privacy.</s><s>Anonymous data is available from the corresponding author on reasonable request.</s></p><p><s>Funding This study was supported in part by an NIH/NCRR CTSA award number UL1 RR025744 and a gift from the Bose Family Foundation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Duality of interest</head><p><s>The authors declare that there is no duality of interest associated with this manuscript.</s></p><p><s>Contribution statement SJ, CJ, GR and SK contributed to the study design.</s><s>GR and SK contributed to data acquisition.</s><s>SJ wrote the manuscript and researched data.</s><s>CJ contributed to the discussion.</s><s>GR reviewed/ edited the manuscript.</s><s>SK researched data and reviewed/edited the manuscript.</s><s>All authors drafted or revised the article and approved the final version of the manuscript.</s><s>SK is the guarantor of this work, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Differentiation of diabetes by pathophysiology, natural history, and prognosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Skyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Bakris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bonifacio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="241" to="255" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Alterations in the glucose-stimulated insulin secretory doseresponse curve and in insulin clearance in nondiabetic insulinresistant individuals</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Staris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1834" to="1838" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Diagnosis and classification of diabetes mellitus</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S62" to="S69" />
			<date type="published" when="2011">2011</date>
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test</title>
		<author>
			<persName><forename type="first">D</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bhargava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="843" to="845" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Greenfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Doberne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kraemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tobey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Reaven</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="387" to="392" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Knowles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Assimes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Tssao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="548" to="553" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Roles of insulin resistance and obesity in regulation of plasma insulin concentrations</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abbasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carantoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="E501" to="E508" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Rosiglitazone reduces glucosestimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abbasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Chu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="2447" to="2452" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance</title>
		<author>
			<persName><forename type="first">E</forename><surname>Van Cauter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mestrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sturis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Polonsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="368" to="377" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">I</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Hyperinsulinemia in individuals with obesity: role of insulin clearance</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="2430" to="2434" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ariel</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Hepatic and extrahepatic insulin clearance are differentially regulated: results from a novel model-based analysis of intravenous glucose tolerance data</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Polidori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Sumner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1556" to="1564" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Quantitative study of insulin secretion and clearance in normal and obese subjects</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Given</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hirsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="435" to="441" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bonora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Zavaroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bruschi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1121" to="1127" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Hyperinsulinemia of obesity is due to decreased clearance of insulin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Meistas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kowarski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Phys</title>
		<imprint>
			<biblScope unit="volume">245</biblScope>
			<biblScope unit="page" from="E155" to="E159" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Dissecting the relationship between obesity and hyperinsulinemia: role of insulin secretion and insulin clearance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obesity</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="378" to="383" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Beta-cell &quot;rest&quot; accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ellmerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Kirkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Bergman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="E1581" to="E1589" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Choudhury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Sanyal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Liver Dis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="575" to="594" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Insulin degradation: progress and potential</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Duckworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Hamel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="608" to="624" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Effect of liver fat on insulin clearance</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kotronen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vehkavaara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Seppälä-Lindroos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bergholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yki-Järvinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="E1709" to="E1715" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Interactions between insulin resistance and insulin secretion in the development of glucose intolerance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Cavaghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Ehrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Polonsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="329" to="333" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The role of incretins in glucose homeostasis and diabetes treatment</title>
		<author>
			<persName><forename type="first">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Egan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="470" to="512" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
